Dishman Pharmaceuticals & Chemicals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Sep ' 16	Mar ' 16	Sep ' 15	Sep ' 14	Sep ' 13

Sales

213.08

272.61

237.78

199.59

211.38

Operating profit

76.03

100.20

70.58

61.96

64.66

Interest

26.27

25.07

43.59

30.00

37.49

Gross profit

80.36

78.66

85.84

60.41

32.55

EPS (Rs)

2.86

4.87

5.93

3.34

0.80

Other income

30.60

3.54

58.84

28.46

5.38

Stock adjustment

-8.62

-0.21

9.07

-25.40

-13.71

Raw material

70.22

89.80

89.27

93.66

96.73

Power and fuel

-

-16.46

16.46

-

-

Employee expenses

35.28

35.26

30.63

29.25

28.20

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

40.17

64.03

21.76

40.13

35.50

Provisions made

-

-

-

-

-

Depreciation

22.68

22.06

22.19

22.16

22.53

Taxation

11.51

17.31

15.79

11.30

3.58

Net profit / loss

46.17

39.30

47.85

26.96

6.44

Extra ordinary item

-

-

-

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

32.28

16.14

16.14

16.14

16.14

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

311.49

311.49

311.77

Agg.of non promotoholding (%)

-

-

38.60

38.60

38.63

OPM (%)

35.68

36.76

29.68

31.04

30.59

GPM (%)

32.98

28.49

28.94

26.49

15.02

NPM (%)

18.95

14.23

16.13

11.82

2.97